3D Signatures Announces Close of Private Placement With Strategic Partner and Prospectus Update Life Science Investing
Isodiol International Inc. Commences Approval Process to Bring Isodiol to Chilean Market Biotech Investing
Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab Presented at IDWeek 2017™ Pharmaceutical Investing
Vitality Biopharma Achieves Cannabinoid Pharmaceutical Biosynthesis Breakthrough Pharmaceutical Investing
Emblem Announces Exclusive Agreement with Canntab Therapeutics for Cannabinoid Based Oral Sustained Release Formulation Cannabis Investing News
3D Signatures Announces Private Placement With Strategic Partner and Prospectus Update Biotech Investing
DelMar Pharmaceuticals Presents Poster at AACR's Ovarian Cancer Special Conference on the Mechanistic Rationale for VAL-083 Overcoming Treatment Resistance in Ovarian Cancer Pharmaceutical Investing
Revive Therapeutics Enters into Research Collaboration with Sanyal Biotechnology for Liver Diseases Biotech Investing
Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Trial for Fully Proprietary Lead IO Program, PRS-343 Pharmaceutical Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026
